Ka Bharat Biotech kawa chna ya i tika yada COVID-19 wa tip kam i COVAXIN iwa chna pyn hapoh ka ri India hi da yoh i yei tipmit naka World Health Organization (WHO) hapoh ka Emergency Use Listing (EUL) kamwa da leh ya kiwi ki tika. Ini i tika toh iwa chna deiwa krehlang waka ICMR waka NIV, Pune.
Da ini i tipmit da ka WHO, kiwi ki ri leh da ye ki wow thied ya ini i tika iwa daw yarap ya kiwi ki ri ki wym pu dap tika wow yoh lang ki.
Hapoh India ya ini i tika da sdang wow chna nadooh uni u snem wei ha ki 9 bnai da ye wow pynmih hadooh 55 Million Dose ha ka chi bnai.
Ka Bharat Biotech da booh thong ko wow pynmih hadooh 1 Billion Dose chwa wow kut uni u snem 2021.
Ka Bharat Biotech toh kawa pynmih 16 tylli ki jait tika kawa em yei thaw kreh ha Hyderabad, India wei ki tika wa da pynmih toh neibynta ka Influenza H1N1, Rotavirus, Japanese Encephalitis (JENVAC®), Rabies, Chikungunya, Zika, Cholera wa ya i kjut Typhoid.
— World Health Organization (WHO) (@WHO) November 3, 2021
WHO has granted emergency use listing (EUL) to #COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of #COVID19. pic.twitter.com/dp2A1knGtT
